-
EP4413136
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4413136
| EP4413136 - COMPOSITIONS AND METHODS FOR TREATMENT OF PRION DISEASES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.07.2024 Database last updated on 07.03.2026 | |
| Former | The international publication has been made Status updated on 14.04.2023 | Most recent event Tooltip | 20.01.2026 | Supplementary search report | published on 18.02.2026 [2026/08] | Applicant(s) | For all designated states Atalanta Therapeutics, Inc. 51 Sleeper Street, 7th Floor Boston, MA 02210 / US | [2024/33] | Inventor(s) | 01 /
HASSLER, Matthew Boston, MA 02128 / US | 02 /
CURTIS, Daniel Belmont, MA 02478 / US | 03 /
GALLANT-BEHM, Corrie Wellesley, MA 02481 / US | [2025/44] |
| Former [2024/33] | 01 /
HASSLER, Matthew Boston, MA 02128 / US | ||
| 02 /
CURTIS, Daniel Belmont, MA 02478 / US | Representative(s) | Pohlman, Sandra M. df-mp Patentanwälte Rechtsanwälte PartG mbB Theatinerstraße 16 80333 München / DE | [N/P] |
| Former [2024/33] | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | Application number, filing date | 22879431.9 | 04.10.2022 | [2024/33] | WO2022US77552 | Priority number, date | US202163252035P | 04.10.2021 Original published format: US 202163252035 P | [2024/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023060092 | Date: | 13.04.2023 | Language: | EN | [2023/15] | Type: | A1 Application with search report | No.: | EP4413136 | Date: | 14.08.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.04.2023 takes the place of the publication of the European patent application. | [2024/33] | Search report(s) | International search report - published on: | US | 13.04.2023 | (Supplementary) European search report - dispatched on: | EP | 19.01.2026 | Classification | IPC: | C12N15/113, A61K31/7088, A61P25/28, C07H21/02, A61K31/7105, A61K31/7115 | [2024/33] | CPC: |
C12N15/113 (EP);
C12N15/1138 (US);
A61K31/713 (EP);
C07H21/02 (EP);
A61P25/28 (EP);
C12N2310/14 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/33] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON PRIONENKRANKHEITEN | [2024/33] | English: | COMPOSITIONS AND METHODS FOR TREATMENT OF PRION DISEASES | [2024/33] | French: | COMPOSITIONS ET MÉTHODES DESTINÉES AU TRAITEMENT DE MALADIES À PRIONS | [2024/33] | Entry into regional phase | 11.04.2024 | National basic fee paid | 11.04.2024 | Search fee paid | 11.04.2024 | Designation fee(s) paid | 11.04.2024 | Examination fee paid | Examination procedure | 11.04.2024 | Examination requested [2024/33] | 15.11.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 28.10.2024 | Renewal fee patent year 03 | 27.10.2025 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] WO2012177639 (ALNYLAM PHARMACEUTICALS INC et al.) [X] 1-3,10-11 * sequence 334527 * | [PX] WO2022182864 (ALNYLAM PHARMACEUTICALS INC et al.) [PX] 1-4,9-11 * page 143; table 2; sequences 45,46 * | International search | [XA] WO2020106996 (IONIS PHARMACEUTICALS INC et al.) [X] 1-10 * Claim 1, pg 45, In 35-38, Table 9, SEQ ID NO: 568 *[A] 11 | [A] WO2021173984 (UNIV MASSACHUSETTS et al.) [A] 1 * whole doc * |